FDA to put most serious warning on COVID-19 vaccines
Digest more
The FDA’s top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.
The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency ...
The Food and Drug Administration (FDA) signed off Wednesday on an emergency use authorization for the Novavax COVID-19 vaccine for individuals 18 years of age and older. The Novavax vaccine is protein-based. It's made with a more conventional technology ...
There may soon be another COVID-19 vaccine on the market in the U.S. Novavax announced Monday that it has submitted a request to the Food and Drug Administration for emergency use authorization for its vaccine in adults. Unlike the mRNA vaccines from ...